Shop in your local currency and language

Choose another country or region to see specific content for your location and shop online.

United Kingdom
Analytical testing

Evaluation of Cytiva™ syringe filters for PFAS analysis using EPA method 1633A

Apr 6, 2026

 

In this article, we present an evaluation of Cytiva™ syringe filters for PFAS testing workflows aligned with EPA Method 1633A. Because PFAS analysis requires ultra-trace sensitivity, minimizing contamination risk during sample preparation is essential. Using a modified protocol without the solid-phase extraction step, we evaluated Cytiva syringe filters with nylon, regenerated cellulose, and polyethersulfone membranes to determine whether they introduced detectable PFAS compounds or exhibited adsorption that could affect analyte recovery. Our results show that most syringe filters tested did not introduce detectable PFAS, and extracted internal standard (EIS) recoveries remained within acceptance limits. These findings indicate that Cytiva syringe filters can support EPA Method 1633A workflows, although additional studies are recommended to confirm performance under broader conditions.

Introduction

Per- and polyfluoroalkyl substances (PFAS) are a group of synthetic compounds widely used in industrial and consumer products due to their resistance to heat, water, and oil. According to the Agency for Toxic Substances and Disease Registry (ATSDR), PFAS have been used in items such as water-repellent clothing, stain-resistant fabrics, cosmetics, and firefighting foams (1). Their chemical stability means they persist in the environment and accumulate in living organisms due to their extreme resistance to degradation.

Growing concern over the environmental and health impacts of PFAS has led to increased regulatory attention. Exposure to specific PFAS compounds has been associated with elevated cholesterol levels, reduced immune response to vaccines, changes in liver enzymes, pregnancy-induced hypertension, and an increased risk of kidney and testicular cancer (2).

EPA method 1633A is a validated analytical protocol designed to detect 40 PFAS compounds in various environmental matrices including wastewater, surface water, groundwater, soil, sediment, and biological tissues (3). The method relies on solid-phase extraction (SPE) followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) to achieve high sensitivity and reproducibility. Given the method’s ultra-trace detection limits, it is essential to maintain strict control over every step of the sample preparation process for reliable results and compliance with regulatory standards. This includes filtration, which must be carefully evaluated to prevent any risk of contamination. While syringe filters themselves may not contain PFAS, they can contribute to contamination during PFAS testing due to PFAS adsorption or leaching. Studies show that different filter materials exhibit varying degrees of PFAS retention and potential contamination (4). Therefore, careful filter selection and proper rinsing protocols are crucial to minimize PFAS contamination and for accurate results in PFAS analysis. To address these concerns, we designed a study focused on filtration as a potential contamination source. Using a modified EPA Method 1633A approach, the study aimed to determine whether Cytiva syringe filters meet contamination control requirements for PFAS workflows and are suitable for use in regulated environments.

Materials and methods

To assess filtration as a potential contamination source, testing was conducted in the United States by Weck Laboratories, Inc., an ISO/IEC 17025-accredited analytical laboratory with additional DoD ELAP and DoE certifications using LC-MS/MS on an Agilent Ultivo instrument (5).

A modified EPA Method 1633A protocol was applied, excluding the solid-phase extraction step to focus on filtration as a potential contamination source. Multiple syringe filter types were assessed across different membrane materials nylon, regenerated cellulose, and polyethersulfone. Product ranges used include Puradisc™, Acrodisc™, Acrodisc™ PSF, and Whatman GD/X™ filters (Table 1).

Table 1. Cytiva syringe filters evaluated for PFAS contamination using a modified version of EPA Method 1633A

Membrane Includes GMF prefilter Product range
Size and pore size
Lots evaluated
Nylon No Puradisc
25 mm / 0.2 µm
2
Nylon
Yes Whatman GD/X
25 mm / 0.2 µm
3
Nylon
No Acrodisc
25 mm / 0.2 µm
3
Nylon
No Acrodisc PSF
25 mm / 0.2 µm
3
Regenerated cellulose
Yes Whatman GD/X
25 mm / 0.2 µm
2
Regenerated cellulose
No Puradisc
25 mm / 0.2 µm
3
Polyethersulfone
Yes Whatman GD/X
25 mm / 0.2 µm
3
Polyethersulfone
No Puradisc
25 mm / 0.2 µm
3
Supor™ polyethersulfone
No Acrodisc
25 mm / 0.2 µm
3

 

Most products were evaluated across three separate lots, using one filter from each lot for analysis. Puradisc nylon and Whatman GD/X regenerated cellulose were evaluated in only two lots due to availability. Since Puradisc, Acrodisc, and Acrodisc PSF filters use a single membrane, Whatman GD/X filters were included to confirm that their glass microfiber (GMF) prefilter layers, designed to reduce clogging and improve sample throughput, do not introduce PFAS contamination.

In addition to native PFAS determination, EIS compounds were monitored as part of method performance checks in accordance with EPA Method 1633A. Isotopically labeled PFAS EIS compounds were added to each sample at known concentrations prior to sample preparation and were processed through filtration and LC‑MS/MS analysis alongside the native PFAS compounds. Because EIS compounds are close structural analogs of the target analytes and experience the same sample preparation steps, their measured recoveries provide supporting information on potential PFAS losses during filtration and subsequent preparation steps. Acceptable EIS recoveries therefore support that the syringe filter step did not introduce bias through analyte adsorption or analytical interference.

Results and discussion

Results were evaluated against EPA Method 1633A performance expectations, including MDL (method detection limit) and MRL (minimum reporting level), and adhered to the laboratory’s MRL convention to ensure consistency with regulatory standards.

Tables 2 and 4 summarize PFAS detection results across different membrane types (nylon, regenerated cellulose, polyethersulfone) and syringe filter product families (Puradisc, Whatman GD/X, Acrodisc and Acrodisc PSF filters).For each compound, the tables report either the highest concentration detected among all tested lots or ‘ND’ (not detected) if PFAS was below the MDL in every lot.

EIS recoveries within standard acceptance windows are detailed in Tables 3 and 5. They were calculated as the average across all tested lots and served as internal performance indicators supporting that the filtration and analysis steps did not compromise method integrity.

Nylon filters

PFAS analytes were ND in any nylon syringe filters evaluated, including Puradisc, Whatman GD/X, Acrodisc, and Acrodisc PSF filters (Table 2). This outcome suggests that nylon membranes did not contribute measurable PFAS contamination under the conditions evaluated. Importantly, testing of Whatman GD/X filters confirmed that the added GMF prefilter layer did not introduce PFAS contamination, with results consistent with single membrane nylon filters.

Table 2. PFAS detection results for Cytiva nylon syringe filters compared to MDL and MRL values. PFAS detection results for Cytiva nylon syringe filters under modified EPA Method 1633A. All compounds were reported as ND. Whatman GD/X, Acrodisc, and Acrodisc PSF filters were evaluated in three lots. Puradisc nylon filter was evaluated in two lots denoted by an asterisk (*).

PFAS compound Short name EIS
Puradisc nylon*
Whatman GD/X nylon
Acrodisc nylon
Acrodisc PSF nylon
MDL
MRL
[ng/L]
11Chloroeicosafluoro3oxaundecane1sulfonic acid 11Cl-PF3OUdS 13C3-HFPO-DA
ND ND ND ND
22 50
3Perfluoropropyl propanoic acid
3:3 FTCA 13C5-PFPeA
ND
ND ND
ND
12 50
1H,1H,2H,2HPerfluorohexane sulfonic acid
4:2 FTS 13C2-4:2FTS
ND
ND ND
ND 9.2 50
2H,2H,3H,3HPerfluorooctanoic acid
5:3 FTCA 13C5-PFHxA
ND
ND ND
ND 33 50
1H,1H,2H,2HPerfluorooctane sulfonic acid
6:2 FTS 13C2-6:2FTS
ND
ND ND
ND 12 50
3Perfluoroheptyl propanoic acid
7:3 FTCA 13C5-PFHxA
ND
ND ND
ND 12 50
1H,1H,2H,2HPerfluorodecane sulfonic acid
8:2 FTS 13C2-8:2FTS
ND
ND ND
ND 14 50
9Chlorohexadecafluoro3oxanonane1sulfonic acid
9Cl-PF3ONS 13C3-HFPO-DA
ND
ND

ND

ND 18 50
4,8Dioxa3Hperfluorononanoic acid
ADONA 13C3-HFPO-DA
ND
ND ND
ND 18 50
Nethyl perfluorooctanesulfonamide
NEtFOSA
D5-NEtFOSA
ND
ND
ND
ND 17 50
Nethyl perfluorooctanesulfonamidoacetic acid
NEtFOSAA
D5-NEtFOSAA
ND
ND
ND
ND 18 50
Nethyl perfluorooctanesulfonamidoethanol
NEtFOSE
D5-NEtFOSE
ND
ND
ND
ND 10 50
Perfluorooctanesulfonamide
FOSA
13C8-PFOSA
ND
ND
ND
ND 15 100
Hexafluoropropylene oxide dimer acid
HFPO-DA
13C3-HFPO-DA
ND
ND
ND
ND 13 50
Nmethyl perfluorooctanesulfonamide
NMeFOSA
D3-NMeFOSA
ND
ND
ND
ND 20 50
Nmethyl perfluorooctanesulfonamidoacetic acid
NMeFOSAA
D3-NMeFOSAA
ND ND ND ND 9.5 50
Nmethyl perfluorooctanesulfonamidoethanol
NMeFOSE
D3-NMeFOSE ND ND ND ND 18 50
Nonafluoro3,6dioxaheptanoic acid
NFDHA
13C5-PFHxA
ND ND ND ND 12 50
Perfluorooctanoic acid
PFOA
13C8-PFOA
ND ND ND ND 18 50
Perfluorobutanoic acid
PFBA
13C4-PFBA
ND ND ND ND 30 50
Perfluorobutanesulfonic acid
PFBS
13C3-PFBS
ND ND ND ND 14 50
Perfluorodecanoic acid
PFDA
13C6-PFDA
ND ND ND ND 16 50
Perfluorododecanoic acid
PFDoA
13C2-PFDoA
ND ND ND ND 7.8 50
Perfluorododecanesulfonic acid
PFDoS
13C8-PFOS
ND ND ND ND 29 50
Perfluorodecanesulfonic acid
PFDS
13C8-PFOS
ND ND ND ND 20 50
Perfluoro(2ethoxyethane)sulfonic acid
PFEESA
13C5-PFHxA
ND ND ND ND 17 50
Perfluoroheptanoic acid
PFHpA
13C4-PFHpA
ND ND ND ND 20 50
Perfluoroheptanesulfonic acid
PFHpS
13C8-PFOS
ND ND ND ND 18 50
Perfluorohexanoic acid
PFHxA
13C5-PFHxA
ND ND ND ND 50 50
Perfluorohexanesulfonic acid
PFHxS
13C3-PFHxS
ND ND ND ND 19 50
Perfluoro4methoxybutanoic acid
PFMBA
13C5-PFPeA
ND ND ND ND 12 50
Perfluoro3methoxypropanoic acid
PFMPA
13C5-PFPeA
ND ND ND ND 20 50
Perfluorononanoic acid
PFNA
13C9-PFNA
ND ND ND ND 16 50
Perfluorononanesulfonic acid
PFNS
13C8-PFOS
ND ND ND ND 15 50
Perfluorooctanesulfonic acid
PFOS
13C8-PFOS
ND ND ND ND 14 50
Perfluoropentanoic acid
PFPeA
13C5-PFPeA
ND ND ND ND 7.8 50
Perfluoropentanesulfonic acid
PFPeS
13C3-PFHxS
ND ND ND ND 20 50
Perfluorotetradecanoic acid
PFTeDA
13C2-PFTeDA
ND ND ND ND 12 50
Perfluorotridecanoic acid
PFTrDA
Average of 13C2-PFTeDA and 13C2-PFDoA
ND ND ND ND 12 50
Perfluoroundecanoic acid
PFUnA
13C7-PFUnA
ND ND ND ND 18 50

 

EIS recoveries for nylon filters were consistently within EPA method 1633A acceptance limits, averaging approximately 92-122% across all isotopically labeled compounds (Table 3). These results may indicate that nylon membranes did not compromise analyte recovery or method performance, supporting their suitability for use in the tested workflow and similar applications requiring equal or lower sensitivity.

Table 3. Average EIS recovery performance for Cytiva nylon syringe filters versus EPA method 1633A acceptance windows. Average EIS recoveries for Cytiva nylon syringe filters compared to method acceptance ranges. Whatman GD/X, Acrodisc, and Acrodisc PSF filters were evaluated in three lots. Puradisc nylon filter was evaluated in two lots denoted by an asterisk (*).

EIS compound Recovery (%) Puradisc nylon* (%)
Whatman GD/X nylon (%)
Acrodisc nylon (%)
Acrodisc PSF nylon (%)
13C2-4:2 FTS 40-200 95 92 95 95
13C2-6:2 FTS
40-200
118 106 105 106
13C2-8:2 FTS
40-300
104 97 101 101
13C2-PFDoA
10-130
93 94 95 95
13C2-PFTeDA
10-130
97 95 98 98
13C3-PFBS
40-135
99 93 105 105
13C3-PFHxS
40-130
106 103 102 102
13C4-PFBA
5-130
101 97 100 100
13C4-PFHpA
40-130
107 101 102 102
13C5-PFHxA
40-130
105 100 102 102
13C5-PFPeA
40-130
117 107 122 122
13C6-PFDA
40-130
96 97 100 100
13C7-PFUnA
30-130
97 93 95 95
13C8-FOSA
40-130
94 95 94 94
13C8-PFOA
40-130
100 97 102 102
13C8-PFOS
40-130
102 96 97 97
13C9-PFNA
40-130
101 99 95 95
D3-NMeFOSA
10-130
112 104 103 103
D3-NMeFOSAA
40-170
105 99 101 101
D5-NEtFOSA
10-130
112 99 106 106
D5-NEtFOSAA
40-170
108 99 101 101
D7-NMeFOSE
10-130
107 108 103 103
D9-NEtFOSE
10-130
113 98 102 102
13C3-HFPO-DA
40-130
100 105 95 95

 

Regenerated cellulose and polyethersulfone filters

Like nylon, PFAS compounds were not detected in regenerated cellulose (RC) filters and in the majority of polyethersulfone (PES) filters evaluated (Table 4). The only exception was a single lot of Acrodisc Supor PES filter, which contained trace levels of 4:2 FTS, 6:2 FTS, and PFMBA (14, 17, and 14 ng/L, respectively), slightly above the method detection limit (MDL) but well below the minimum reporting level (MRL) of 50 ng/L for all three PFAS compounds. All other PES lots were reported as ND, suggesting that contamination risk is minimal. This also included Whatman GD/X RC and GD/X PES filters, which showed no detectable PFAS despite the presence of a GMF prefilter layer.

Table 4. PFAS detection results for Cytiva RC and PES syringe filters compared to MDL and MRL values. PFAS detection results for Cytiva RC and PES syringe filters under modified EPA method 1633A. Concentrations represent the highest value observed across lots or ND. Puradisc RC and PES, and Acrodisc Supor PES filters were evaluated in three lots. Whatman GD/X RC filter was evaluated in two lots denoted by an asterisk (*).

PFAS compound Short name EIS
Puradisc RC
Whatman GD/X RC*
Puradisc PES
Whatman GD/XPES
Acrodisc Supor PES
MDL
MRL
[ng/L]
11Chloroeicosafluoro3oxaundecane1sulfonic acid 11Cl-PF3OUdS 13C3-HFPO-DA
ND ND ND ND
ND 22 50
3Perfluoropropyl propanoic acid
3:3 FTCA 13C5-PFPeA
ND
ND ND
ND
ND 12 50
1H,1H,2H,2HPerfluorohexane sulfonic acid
4:2 FTS 13C2-4:2FTS
ND
ND ND
ND 14 9.2 50
2H,2H,3H,3HPerfluorooctanoic acid
5:3 FTCA 13C5-PFHxA
ND
ND ND
ND ND 33 50
1H,1H,2H,2HPerfluorooctane sulfonic acid
6:2 FTS 13C2-6:2FTS
ND
ND ND
ND 17 12 50
3Perfluoroheptyl propanoic acid
7:3 FTCA 13C5-PFHxA
ND
ND ND
ND ND 12 50
1H,1H,2H,2HPerfluorodecane sulfonic acid
8:2 FTS 13C2-8:2FTS
ND
ND ND
ND ND 14 50
9Chlorohexadecafluoro3oxanonane1sulfonic acid
9Cl-PF3ONS 13C3-HFPO-DA
ND
ND

ND

ND ND 18 50
4,8Dioxa3Hperfluorononanoic acid
ADONA 13C3-HFPO-DA
ND
ND ND
ND ND 18 50
Nethyl perfluorooctanesulfonamide
NEtFOSA
D5-NEtFOSA
ND
ND
ND
ND ND 17 50
Nethyl perfluorooctanesulfonamidoacetic acid
NEtFOSAA
D5-NEtFOSAA
ND
ND
ND
ND ND 18 50
Nethyl perfluorooctanesulfonamidoethanol
NEtFOSE
D5-NEtFOSE
ND
ND
ND
ND ND 10 50
Perfluorooctanesulfonamide
FOSA
13C8-PFOSA
ND
ND
ND
ND ND 15 100
Hexafluoropropylene oxide dimer acid
HFPO-DA
13C3-HFPO-DA
ND
ND
ND
ND ND 13 50
Nmethyl perfluorooctanesulfonamide
NMeFOSA
D3-NMeFOSA
ND
ND
ND
ND ND 20 50
Nmethyl perfluorooctanesulfonamidoacetic acid
NMeFOSAA
D3-NMeFOSAA
ND ND ND ND ND 9.5 50
Nmethyl perfluorooctanesulfonamidoethanol
NMeFOSE
D3-NMeFOSE ND ND ND ND ND 18 50
Nonafluoro3,6dioxaheptanoic acid
NFDHA
13C5-PFHxA
ND ND ND ND ND 12 50
Perfluorooctanoic acid
PFOA
13C8-PFOA
ND ND ND ND ND 18 50
Perfluorobutanoic acid
PFBA
13C4-PFBA
ND ND ND ND ND 30 50
Perfluorobutanesulfonic acid
PFBS
13C3-PFBS
ND ND ND ND ND 14 50
Perfluorodecanoic acid
PFDA
13C6-PFDA
ND ND ND ND ND 16 50
Perfluorododecanoic acid
PFDoA
13C2-PFDoA
ND ND ND ND ND 7.8 50
Perfluorododecanesulfonic acid
PFDoS
13C8-PFOS
ND ND ND ND ND 29 50
Perfluorodecanesulfonic acid
PFDS
13C8-PFOS
ND ND ND ND ND 20 50
Perfluoro(2ethoxyethane)sulfonic acid
PFEESA
13C5-PFHxA
ND ND ND ND ND 17 50
Perfluoroheptanoic acid
PFHpA
13C4-PFHpA
ND ND ND ND ND 20 50
Perfluoroheptanesulfonic acid
PFHpS
13C8-PFOS
ND ND ND ND ND 18 50
Perfluorohexanoic acid
PFHxA
13C5-PFHxA
ND ND ND ND ND 50 50
Perfluorohexanesulfonic acid
PFHxS
13C3-PFHxS
ND ND ND ND ND 19
50
Perfluoro4methoxybutanoic acid
PFMBA
13C5-PFPeA
ND ND ND ND 14 12
50
Perfluoro3methoxypropanoic acid
PFMPA
13C5-PFPeA
ND ND ND ND ND 20
50
Perfluorononanoic acid
PFNA
13C9-PFNA
ND ND ND ND ND 16
50
Perfluorononanesulfonic acid
PFNS
13C8-PFOS
ND ND ND ND ND 15
50
Perfluorooctanesulfonic acid
PFOS
13C8-PFOS
ND ND ND ND ND 14
50
Perfluoropentanoic acid
PFPeA
13C5-PFPeA
ND ND ND ND ND 7.8
50
Perfluoropentanesulfonic acid
PFPeS
13C3-PFHxS
ND ND ND ND ND 20
50
Perfluorotetradecanoic acid
PFTeDA
13C2-PFTeDA
ND ND ND ND ND 12
50
Perfluorotridecanoic acid
PFTrDA
Average of 13C2-PFTeDA and 13C2-PFDoA
ND ND ND ND ND 12
50
Perfluoroundecanoic acid
PFUnA
13C7-PFUnA
ND ND ND ND ND 18
50

EIS recoveries for RC and PES filters were generally within EPA method 1633A acceptance ranges, as shown in Table 5. Puradisc and Whatman GD/X RC filters ranged from 94% to 128%, confirming stable performance. Puradisc and Whatman GD/X PES filters ranged from 91% to 122%, also within acceptable limits. One exception was Acrodisc Supor PES filter, which showed an outlier average recovery of 148% for 13C5-PFPeA, coinciding with the lot that exhibited PFAS detections. This anomaly is most plausibly due to matrix or coelution effects, where trace PFAS or other co‑extracted species may have enhanced EIS signals during LC‑MS/MS analysis, rather than indicating true recovery loss. Despite this, all other EIS recoveries for Acrodisc Supor PES filter remained within acceptable limits (93–116%), consistent with overall method integrity.

Table 5. Average EIS recovery performance for Cytiva RC and PES syringe filters versus EPA method 1633A acceptance windows. Average EIS recoveries for Cytiva RC and PES syringe filters compared to method acceptance ranges. Puradisc RC and PES, and Acrodisc Supor PES filters were evaluated in three lots. Whatman GD/X RC filter was evaluated in two lots and is marked with an asterisk (*).

EIS compound Recovery (%) Puradisc RC (%)
Whatman GD/X RC* (%)
Puradisc PES (%)
Whatman GD/X PES (%)
Acrodisc Supor PES (%)
13C2-4:2 FTS 40-200 110 99 96 99 113
13C2-6:2 FTS
40-200
105 111 100 101 101
13C2-8:2 FTS
40-300
98 100 94 96 93
13C2-PFDoA
10-130
94 99 95 92 94
13C2-PFTeDA
10-130
95 100 95 103 96
13C3-PFBS
40-135
118
117 106 112 116
13C3-PFHxS
40-130
110
98 97 103 100
13C4-PFBA
5-130
97
95 100 101 100
13C4-PFHpA
40-130
106
104 105 101 98
13C5-PFHxA
40-130
106
105 96 104 103
13C5-PFPeA
40-130
128
115 115 122 148
13C6-PFDA
40-130
97
92 93 100 98
13C7-PFUnA
30-130
94
92 91 99 99
13C8-FOSA
40-130
94
96 94 97 95
13C8-PFOA
40-130
95
99 95 94 99
13C8-PFOS
40-130
101
94 99 95 99
13C9-PFNA
40-130
104
100 100 104 101
D3-NMeFOSA
10-130
103
106 104 107
109
D3-NMeFOSAA
40-170
103
105 100 97
99
D5-NEtFOSA
10-130
105
108 102 101
104
D5-NEtFOSAA
40-170
102
106 97 99
94
D7-NMeFOSE
10-130
103
111 102 114
104
D9-NEtFOSE
10-130
101
105 104 102
102
13C3-HFPO-DA
40-130
101 99 95 100 94

Conclusion

Testing under a modified EPA method 1633A demonstrated that Cytiva syringe filters generally do not introduce detectable PFAS compounds at the sensitivity level used in this study. All tested lots of nylon and regenerated cellulose syringe filters—across multiple product ranges—showed no detectable PFAS compounds. Polyethersulfone filters also showed no detectable PFAS in nearly all lots. However, one lot of Acrodisc Supor PES filter exhibited trace amounts of three PFAS compounds (4:2 FTS, 6:2 FTS, and PFMBA) slightly above the method detection limit (MDL) but below the minimum reporting level (MRL). EIS recoveries were within method acceptance limits for nearly all syringe filters, with a single outlier(13C5-PFPeA) in the same Acrodisc Supor PES filter lot that showed trace PFAS. Taken together with the native analyte results, the findings support reliable analyte recovery across the evaluated products.

Importantly, Whatman GD/X filters, which include GMF prefilter layers, were tested for PFAS contamination and showed no detectable PFAS, indicating that the additional prefilter material did not introduce contamination under the conditions evaluated.

For customers or users working with PFAS workflows, it is important to note that, given the limited number of samples and conditions tested, additional studies across more products, matrices, and method steps are recommended to confirm these results under broader scenarios. Although these findings apply specifically to EPA method 1633A, they may offer helpful preliminary guidance for evaluating syringe filter performance in other PFAS related standards and test methods, which remain a critical area for future research.

References
  1. CDC. Per- and Polyfluoroalkyl Substances (PFAS) and Your Health. Centers for Disease Control and Prevention. Published October 22, 2019. https://www.atsdr.cdc.gov/pfas/index.html
  2. CDC. How PFAS Impacts Your Health. Per- and Polyfluoroalkyl Substances (PFAS) and Your Health. Published November 7, 2024. https://www.atsdr.cdc.gov/pfas/about/health-effects.html
  3. Method 1633, Revision a Analysis of Per-and Polyfluoroalkyl Substances (PFAS) in Aqueous, Solid, Biosolids, and Tissue Samples by LC-MS/MS.; 2024. https://www.epa.gov/system/files/documents/2024-12/method-1633a-december-5-2024-508-compliant.pdf
  4. Morishita KN, Lee H, Han C, Niu XZ. Syringe Filters and Autosampler Vials Impact on Analysis of Long-, Short-, and Ultrashort-Chain Per- and Polyfluoroalkyl Substances. ACS ES&T Water. 2025;5(3):1344-1352. doi:10.1021/acsestwater.4c01090
  5. Certifications. Wecklabs.com. Published 2017. Accessed December 2, 2025. https://www.wecklabs.com/Resources/Information/Certifications.aspx
Discover how to protect your HPLC columns and instruments with high-performance filtration devices
Ensure smoother HPLC operation with sample and mobile phase filtration that prevents particulate buildup and reduces instrument wear and downtime

Did you find what you were looking for?